The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 556-561

  Pellegriti, Gabriella ^a   Scollo, Claudia ^a   Regalbuto, Concetto ^a   Attard, Marco ^b   Marozzi, Paola ^b   Vermiglio, Francesco ^c   Violi, Maria Antonella ^c   Cianci, Michelangela ^d   Vigneri, Riccardo ^a   Pezzino, Vincenzo ^a,d   Squatrito, Sebastiano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d GARIBALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; LEVOTHYROXINE; THYROGLOBULIN; THYROTROPIN;

ADULT; ARTICLE; CANCER HORMONE THERAPY; CANCER MORTALITY; CHRONOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EVALUATION; FEMALE; HORMONAL REGULATION; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT CANCER; SERODIAGNOSIS; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

ADULT; CARCINOMA, PAPILLARY; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID HORMONES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TUMOR MARKERS, BIOLOGICAL; WHOLE-BODY COUNTING;

EID: 0038332171     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01744.x     Document Type: Article

References (25)

1. Braverman, L.E., Pratt, B.M., Ebner, S. & Longcope, C. (1992) Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey. Journal of Clinical Endocrinology and Metabolism, 74, 1135-1139.
2. Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M. & Schlumberger, M. (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Journal of Clinical Endocrinology and Metabolism, 85, 175-178.
3. Dow, K.H., Ferrel, B.R. & Anello, C. (1997) Quality of life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid, 7, 613-619.
4. 131I uptake post-thyroidectomy for thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 50, 734-739.
5. Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., Cooper, D.S., Graham, K.E., Braverman, L.E., Skarulis, M.C., Davies, T.F., DeGroot, L.J., Mazzaferri, E.L., Daniels, G.H., Ross, D.S., Luster, M., Samuels, M.H., Becker, D.V., Maxon, H.R., 3rd, Cavalieri, R.R., Spencer, C.A., McEllin, K., Weintraub, B.D. & Ridgway, E.C. (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism, 84, 3877-3885.
6. Haugen, B.R., Ridgway, E.C.M.C., Laughlin, B.A. & McDermott, M.T. (2002) Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid, 12, 37-43.
7. Hermanek, P. & Sobin, L.H. (1992) Thyroid Gland (ICD-Oc73). TNM Classification of Malignant Tumors, 4th edn, 2nd revision, pp. 35-37. Springer-Verlag, Berlin.
8. Ladenson, P.W., Braverman, L.E., Mazzaferri, E.L., Brucker-Davis, F., Cooper, D.S., Garber, J.R., Wondisford, F.E., Davies, T.F., DeGroot, L.J., Daniels, G.H., Ross, D.S. & Weintraub, B.D. (1997) Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. New England Journal of Medicine, 337, 888-896.
9. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
10. Mazzaferri, E.L. & Kloos, R.T. (2001) Current approach to primary therapy for papillary and follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 1447-1463.
11. Mazzaferri, E.L. & Kloos, R.T. (2002) Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? Journal of Clinical Endocrinology and Metabolism, 87 (1490), 1498.
12. Meier, C.A., Braverman, L.E., Ebner, S.A., Veronikis, I., Daniels, G.H., Ross, D.S., Deraska, D.J., Davies, T.F., Valentine, M., DeGroot, L.J., Curran, P., McEllin, K., Reynolds, J., Robbins, J. & Weintraub, B.D. (1994) Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). Journal of Clinical Endocrinology and Metabolism, 78, 188-196.
13. Ozata, M., Suzuki, S., Miyamoto, T., Liu, R.T., Fierro-Renoy, F. & DeGroot, L.J. (1994) Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 79, 98-105.
14. Pacini, F. & Lippi, F. (1999) Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement. Journal of Endocrinological Investigation, 22, 25-29 (Suppl. n. 11).
15. Pacini, F., Lari, R., Mazzeo, S., Grasso, L., Taddei, D. & Pinchera, A. (1985) Diagnostic value of a single serum thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer. Clinical Endocrinology, 23, 405-411.
16. Pacini, F., Molinaro, E., Lippi, F., Castagna, M.G., Agate, L., Ceccarelli, C., Taddei, D., Elisei, R., Capezzone, M. & Pinchera, A. (2001) Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 5686-5690.
17. Pacini, F., Capezzone, M., Elisei, R., Ceccarelli, C., Taddei, D. & Pinchera, A. (2002) Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. Journal of Clinical Endocrinology and Metabolism, 87, 1499-1501.
18. Robbins, R.J., Tuttle, R.M., Sharaf, R.N., Larson, S.M., Robbins, H.K., Ghossein, R.A., Smith, A. & Drucker, W.D. (2001) Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 619-625.
19. Robbins, R.J., Chon, J.T., Fleisher, M., Larson, S.M. & Tuttle, R.M. (2002) Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? Journal of Clinical Endocrinology and Metabolism, 87, 3242-3247.
20. Schlumberger, M.J. (1998) Papillary and follicular thyroid carcinoma. New England Journal of Medicine, 338, 297-306.
21. Schlumberger, M.J. & Baudin, E. (1998) Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. European Journal of Endocrinology, 138, 249-252.
22. Schlumberger, M.J., Incerti, C., Pacini, F. & Reiners, C. (1999) The role of recombinant thyroid-stimulating hormone (rhTSH) in the detection and management of well-differentiated thyroid carcinoma: a roundtable discussion. Journal of Endocrinological Investigation, 22(Suppl. n. 11), 35-41.
23. Schlumberger, M., Ricard, M. & Pacini, F. (2000) Clinical use of recombinant human TSH (rhTSH) in thyroid cancer patients. European Journal of Endocrinology, 143, 557-563.
24. Spencer, C.A., LoPresti, J.S., Fatemi, S. & Nicoloff, J.T. (1999) Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement. Thyroid, 9, 435-441.
25. Utiger, R.D. (1997) Follow-up of patients with thyroid carcinoma. New England Journal of Medicine, 337, 928-930.